# Baxter Healthcare Corporation – FDA Inspection, May 12, 2022

Source: https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/ce5076b5-1e62-4a8e-b708-c17c96eee53e
Source feed: FDA_Inspections

> FDA inspection 1169330 of Baxter Healthcare Corporation, May 12, 2022. Classification: Official Action Indicated (OAI). 11 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1169330
- Company Name: Baxter Healthcare Corporation
- Inspection Date: 2022-05-12
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1299166 - 2026-08-20](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/595951df-0e05-46ff-bfc1-f458d01d58e5)
- [FDA Inspection 1230544 - 2024-02-09](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/af306a83-c8f6-4639-8e6c-5d8b74cc7791)
- [FDA Inspection 1221559 - 2023-10-31](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/e56f6b7d-ffa0-4a4e-b741-2e06fe829dff)
- FDA Inspection 1151566 - 2021-07-01
- [FDA Inspection 1031655 - 2017-11-17](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/c70d8cf6-ee98-4a1e-9d34-422e372ef98d)

Company: https://www.keypedia.com/companies/baxter-healthcare-corporation/19a30564-2115-4586-a055-e1b5efcf06ee

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
